VRSK vs. DXCM

Last updated Apr 2, 2026

Compare and contrast key facts about Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM).

Performance

VRSK vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

VRSK vs. DXCM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRSK Verisk Analytics, Inc.	-17.76%	-18.23%	16.00%	36.24%	-22.33%	10.85%	39.89%	37.92%	13.58%	18.27%
DXCM DexCom, Inc.	-6.03%	-14.66%	-37.33%	9.58%	-15.64%	45.23%	69.02%	82.59%	108.75%	-3.87%

Fundamentals

Market Cap VRSK : $25.53B DXCM : $24.88B
EPS VRSK : $6.50 DXCM : $2.07
PE Ratio VRSK : 28.24 DXCM : 30.19
PEG Ratio VRSK : 1.59 DXCM : 0.72
PS Ratio VRSK : 33.39 DXCM : 5.42
Total Revenue (TTM) VRSK : $768.30M DXCM : $4.66B
Gross Profit (TTM) VRSK : $538.80M DXCM : $2.80B
EBITDA (TTM) VRSK : $1.42B DXCM : $1.34B

Returns By Period

In the year-to-date period, VRSK achieves a -17.76% return, which is significantly lower than DXCM's -6.03% return. Over the past 10 years, VRSK has underperformed DXCM with an annualized return of 9.15%, while DXCM has yielded a comparatively higher 13.94% annualized return.

VRSK

• 1D: -3.29%
• 1M: -14.35%
• YTD: -17.76%
• 6M: -26.13%
• 1Y: -38.07%
• 3Y*: -0.83%
• 5Y*: 1.07%
• 10Y*: 9.15%

DXCM

• 1D: -0.68%
• 1M: -15.46%
• YTD: -6.03%
• 6M: -5.61%
• 1Y: -7.35%
• 3Y*: -18.73%
• 5Y*: -7.35%
• 10Y*: 13.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VRSK vs. DXCM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRSK

VRSK Risk / Return Rank: 6
VRSK Sharpe Ratio Rank: 1
VRSK Sortino Ratio Rank: 3
VRSK Omega Ratio Rank: 3
VRSK Calmar Ratio Rank: 12
VRSK Martin Ratio Rank: 8

DXCM

DXCM Risk / Return Rank: 32
DXCM Sharpe Ratio Rank: 32
DXCM Sortino Ratio Rank: 30
DXCM Omega Ratio Rank: 30
DXCM Calmar Ratio Rank: 34
DXCM Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRSK vs. DXCM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VRSK	DXCM	Difference
Sharpe ratio Return per unit of total volatility	-1.29	-0.17	-1.12
Sortino ratio Return per unit of downside risk	-1.78	0.06	-1.84
Omega ratio Gain probability vs. loss probability	0.76	1.01	-0.25
Calmar ratio Return relative to maximum drawdown	-0.81	-0.22	-0.58
Martin ratio Return relative to average drawdown	-1.51	-0.45	-1.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VRSK vs. DXCM - Sharpe Ratio Comparison

The current VRSK Sharpe Ratio is -1.29, which is lower than the DXCM Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of VRSK and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	VRSK	DXCM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.29	-0.17	-1.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	-0.16	+0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.39	0.29	+0.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.56	0.29	+0.27

Correlation

The correlation between VRSK and DXCM is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VRSK vs. DXCM - Dividend Comparison

VRSK's dividend yield for the trailing twelve months is around 1.01%, while DXCM has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019
VRSK Verisk Analytics, Inc.	1.01%	0.80%	0.57%	0.57%	0.70%	0.51%	0.52%	0.67%
DXCM DexCom, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

VRSK vs. DXCM - Drawdown Comparison

The maximum VRSK drawdown since its inception was -46.98%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for VRSK and DXCM.

Drawdown Indicators

	VRSK	DXCM	Difference
Max Drawdown Largest peak-to-trough decline	-46.98%	-94.61%	+47.63%
Max Drawdown (1Y) Largest decline over 1 year	-46.98%	-38.75%	-8.23%
Max Drawdown (5Y) Largest decline over 5 years	-46.98%	-66.32%	+19.34%
Max Drawdown (10Y) Largest decline over 10 years	-46.98%	-66.32%	+19.34%
Current Drawdown Current decline from peak	-42.45%	-61.69%	+19.24%
Average Drawdown Average peak-to-trough decline	-6.79%	-35.79%	+29.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.01%	19.36%	+5.65%

Volatility

VRSK vs. DXCM - Volatility Comparison

Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM) have volatilities of 9.42% and 9.22%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VRSK	DXCM	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.42%	9.22%	+0.20%
Volatility (6M) Calculated over the trailing 6-month period	24.77%	27.60%	-2.83%
Volatility (1Y) Calculated over the trailing 1-year period	29.61%	43.67%	-14.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.67%	46.76%	-23.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.53%	48.30%	-24.77%

Financials

VRSK vs. DXCM - Profitability Comparison

The chart below illustrates the profitability comparison between Verisk Analytics, Inc. and DexCom, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VRSK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported a gross profit of -1.07B and revenue of -1.53B. Therefore, the gross margin over that period was 69.8%.

DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a gross profit of 792.70M and revenue of 1.26B. Therefore, the gross margin over that period was 62.9%.

VRSK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported an operating income of -684.40M and revenue of -1.53B, resulting in an operating margin of 44.9%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported an operating income of 323.00M and revenue of 1.26B, resulting in an operating margin of 25.6%.

VRSK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported a net income of 197.20M and revenue of -1.53B, resulting in a net margin of -12.9%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a net income of 267.30M and revenue of 1.26B, resulting in a net margin of 21.2%.